• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Controlling liver cancer mortality on a global scale: Still a long way to go.

作者信息

Colombo Massimo, Maisonneuve Patrick

机构信息

Humanitas Clinical and Research Center, Rozzano, Italy.

European Institute of Oncology, Milan, Italy.

出版信息

J Hepatol. 2017 Aug;67(2):216-217. doi: 10.1016/j.jhep.2017.05.004. Epub 2017 May 12.

DOI:10.1016/j.jhep.2017.05.004
PMID:28506906
Abstract
摘要

相似文献

1
Controlling liver cancer mortality on a global scale: Still a long way to go.在全球范围内控制肝癌死亡率：仍有很长的路要走。
J Hepatol. 2017 Aug;67(2):216-217. doi: 10.1016/j.jhep.2017.05.004. Epub 2017 May 12.
2
Application of the King's score as a prognostic model for hepatocellular carcinoma: still a long way to go.将国王评分作为肝细胞癌预后模型的应用：仍有很长的路要走。
Liver Int. 2016 May;36(5):764. doi: 10.1111/liv.12864. Epub 2015 May 16.
3
"Survival benefit": the final destination, with still a long way to go.“生存获益”：终极目标，仍有漫漫长路要走。
Dig Liver Dis. 2010 Sep;42(9):608-10. doi: 10.1016/j.dld.2010.07.001.
4
CAHECA: computer aided hepatocellular carcinoma therapy planning.CAHECA：计算机辅助肝细胞癌治疗规划
Interdiscip Sci. 2014 Sep;6(3):222-34. doi: 10.1007/s12539-013-0204-7. Epub 2014 Sep 11.
5
[Recent advances and controversies in surgical management of hepatocellular carcinoma of hepatocellular carcinoma].[肝细胞癌外科治疗的最新进展与争议]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):378-80.
6
Spontaneous rupture of hepatocellular carcinoma: a systematic review.肝细胞癌自发性破裂：一项系统综述
Arch Surg. 2006 Feb;141(2):191-8. doi: 10.1001/archsurg.141.2.191.
7
[Effective evaluation of liver transplantation for hepatocellular carcinoma].[肝细胞癌肝移植的有效评估]
Zhonghua Yi Xue Za Zhi. 2004 Sep 17;84(18):1533-5.
8
[Liver transplantation for advanced primary hepatocellular carcinoma].[晚期原发性肝细胞癌的肝移植]
Zhonghua Zhong Liu Za Zhi. 2003 May;25(3):295-7.
9
The evolving epidemiology of hepatocellular carcinoma: a global perspective.肝细胞癌不断演变的流行病学：全球视角
Expert Rev Gastroenterol Hepatol. 2015 Jun;9(6):765-79. doi: 10.1586/17474124.2015.1028363. Epub 2015 Apr 1.
10
Multidisciplinary Care in Hepatocellular Carcinoma: Where Do We Go From Here?肝细胞癌的多学科护理：我们从这里走向何方？
Gastroenterology. 2017 Jun;152(8):1823-1825. doi: 10.1053/j.gastro.2017.04.029. Epub 2017 Apr 28.

引用本文的文献

1
Nanoliposome C6-Ceramide in combination with anti-CTLA4 antibody improves anti-tumor immunity in hepatocellular cancer.纳米脂质体 C6-神经酰胺联合抗 CTLA4 抗体可改善肝癌的抗肿瘤免疫。
FASEB J. 2022 Apr;36(4):e22250. doi: 10.1096/fj.202101707R.
2
Lactonic sophorolipid-induced apoptosis in human HepG2 cells through the Caspase-3 pathway.乳酮型槐糖脂诱导人 HepG2 细胞通过 Caspase-3 途径凋亡。
Appl Microbiol Biotechnol. 2021 Mar;105(5):2033-2042. doi: 10.1007/s00253-020-11045-5. Epub 2021 Feb 13.
3
Time serial transcriptome reveals as a key gene in hepatocellular carcinoma development.
时间序列转录组揭示 为肝癌发展的关键基因。
Cancer Biol Med. 2020 May 15;17(2):401-417. doi: 10.20892/j.issn.2095-3941.2019.0335.
4
Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity.肝细胞癌中的索拉非尼耐药性：基因异质性的相关性
Cancers (Basel). 2020 Jun 15;12(6):1576. doi: 10.3390/cancers12061576.
5
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis.一种在肝脏炎症和纤维化背景下由致癌肝细胞诱导的原位肝癌小鼠模型。
J Vis Exp. 2019 Sep 12(151). doi: 10.3791/59368.
6
Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis.全球因注射吸毒导致的肝硬化和肝癌死亡负担，1990-2016 年：年龄-时期-队列和空间自相关分析。
Int J Environ Res Public Health. 2018 Jan 22;15(1):170. doi: 10.3390/ijerph15010170.